S. Adams, R. Bough, E. Cliffe, B. Lessel, and R. Mills, Absorption, distribution and toxicity of ibuprofen, Toxicology and Applied Pharmacology, vol.15, issue.2, pp.310-340, 1969.
DOI : 10.1016/0041-008X(69)90032-5

C. Adeyeye, J. Bricker, V. Vilivalam, and W. Smith, Acute gastrointestinal toxic effects of 745 suspensions of unencapsulated and encapsulated ibuprofen in rats, Pharmaceutical Research, vol.13, issue.5, pp.784-93, 1996.
DOI : 10.1023/A:1016068104462

H. Taehti, E. Testai, J. Van-delft, H. Van-loveren, M. Vinken et al., Alternative 753 (non-animal) methods for cosmetics testing: current status and future prospects-2010, pp.367-485, 2011.

J. Weber and L. Richert, Plateable cryopreserved human hepatocytes for the assessment of 757 cytochrome P450 inducibility: experimental condition-related variables affecting their response to 758 inducers, Xenobiotica, vol.42, pp.968-79, 2012.

C. Aninat, A. Piton, D. Glaise, L. Charpentier, T. Langouët et al., Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human 761 hepatoma HepaRG cells, Drug Metab Dispos, vol.34, pp.760-75, 2006.

C. Guguen-guillouzo and A. Guillouzo, Stable expression, activity, and inducibility of 764 cytochromes P450 in differentiated HepaRG cells, Drug Metab Dispos, vol.38, pp.516-541, 2010.

S. Anthérieu, C. Chesné, R. Li, C. Guguen-guillouzo, and A. Guillouzo, Optimization of the HepaRG cell model for drug metabolism and toxicity studies, Toxicology in Vitro, vol.26, issue.8, pp.1278-85, 2012.
DOI : 10.1016/j.tiv.2012.05.008

J. Armitage, F. Wania, and J. Arnot, Application of Mass Balance Models and the Chemical Activity Concept To Facilitate the Use of in Vitro Toxicity Data for Risk Assessment, Environmental Science & Technology, vol.48, issue.16, pp.9770-9779, 2014.
DOI : 10.1021/es501955g

R. Bauer, S. Guzy, and C. Ng, A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples, The AAPS Journal, vol.9, issue.1, pp.60-83, 2007.
DOI : 10.1208/aapsj0901007

W. Bennett, . Jr, Y. Turmelle, and R. Shepherd, Ibuprofen-Induced Liver Injury in an Adolescent Athlete, Clinical Pediatrics, vol.132, issue.1, pp.84-90, 2009.
DOI : 10.1177/0009922808320797

F. Bois, GNU MCSim: Bayesian statistical inference for SBML-coded systems biology models, Bioinformatics, vol.25, issue.11, pp.1453-1457, 2009.
DOI : 10.1093/bioinformatics/btp162
URL : https://hal.archives-ouvertes.fr/ineris-00961935

F. Bois, M. Jamei, and H. Clewell, PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals, Toxicology, vol.278, issue.3, pp.256-67, 2010.
DOI : 10.1016/j.tox.2010.06.007
URL : https://hal.archives-ouvertes.fr/ineris-00961755

M. Castillo, Y. Lam, M. Dooley, E. Stahl, and P. Smith, Disposition and covalent binding of ibuprofen and its acyl glucuronide in the elderly*, Clinical Pharmacology & Therapeutics, vol.38, issue.6, pp.636-680, 1995.
DOI : 10.1016/0009-9236(95)90226-0

C. Guillouzo and A. Corlu, Transdifferentiation of hepatocyte-like cells from the human 782 hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.45, pp.957-67, 2007.

S. Chang, W. Li, S. Traeger, B. Wang, D. Cui et al., Confirmation That Cytochrome P450 2C8 (CYP2C8) Plays a Minor Role in (S)-(+)- and (R)-(-)-Ibuprofen Hydroxylation in Vitro, Drug Metabolism and Disposition, vol.36, issue.12, pp.2513-2535, 2008.
DOI : 10.1124/dmd.108.022970

E. Testai and J. Zaldívar, Toxicokinetics as a key to the integrated toxicity risk assessment 788 based primarily on non-animal approaches, Toxicol In vitro, vol.27, pp.1570-1577, 2013.

J. Dong and P. Smith, Glucuronidation and Covalent Protein Binding of Benoxaprofen and Flunoxaprofen in Sandwich-Cultured Rat and Human Hepatocytes, Drug Metabolism and Disposition, vol.37, issue.12, pp.2314-791, 2009.
DOI : 10.1124/dmd.109.028944

A. Gelman and R. Db, Inference from Iterative Simulation Using Multiple Sequences, Statistical Science, vol.7, issue.4, pp.457-511, 1992.
DOI : 10.1214/ss/1177011136

A. Gelman, F. Bois, and J. Jiang, Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996.
DOI : 10.2307/2533402

C. Guguen-guillouzo, Infection of a human hepatoma cell line by hepatitis B virus, Proc Natl, p.798, 2002.

F. Groothuis, M. Heringa, B. Nicol, J. Hermens, B. Blaauboer et al., Dose metric 800 considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. 801 Toxicology, 2013.

A. Guillouzo, Liver cell models in in vitro toxicology, Environ Health, vol.106, pp.511-543, 1998.

M. Guelden, S. Moerchel, and H. Seibert, Factors influencing nominal effective concentrations of chemical compounds in vitro: cell concentration, Toxicology in Vitro, vol.15, issue.3, pp.233-276, 2001.
DOI : 10.1016/S0887-2333(01)00008-X

M. Guelden, J. A. Kammann, J. Maser, E. Seibert, and H. , Cytotoxic potency of H2O2 in cell cultures: Impact of cell concentration and exposure time, Free Radical Biology and Medicine, vol.49, issue.8, pp.1298-305, 2010.
DOI : 10.1016/j.freeradbiomed.2010.07.015

M. Hamman, G. Thompson, and S. Hall, Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C, Biochemical Pharmacology, vol.54, issue.1, pp.33-41, 1997.
DOI : 10.1016/S0006-2952(97)00143-3

A. Hassan, A. Sapin, N. Ubrich, P. Maincent, C. Bolzan et al., Simple and Sensitive HPLC Method with Fluorescence Detection for the Measurement of Ibuprofen in Rat Plasma: Application to a Long-Lasting Dosage Form, Drug Development and Industrial Pharmacy, vol.65, issue.10, pp.1064-70, 2008.
DOI : 10.1248/yakushi.125.733

J. Hengstler, Primary hepatocytes: current understanding of the regulation of metabolic 815 enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in 816 metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies, pp.159-234, 2007.

L. Hu, Y. J. Liu, W. Li, and L. , Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability, Drug Delivery, vol.58, issue.1, pp.90-95, 2011.
DOI : 10.1016/j.ijpharm.2008.04.008

R. Jossé, C. Aninat, D. Glaise, J. Dumont, V. Fessard et al., Long-Term Functional Stability of Human HepaRG Hepatocytes and Use for Chronic Toxicity and Genotoxicity Studies, Drug Metabolism and Disposition, vol.36, issue.6, pp.1111-1119
DOI : 10.1124/dmd.107.019901

K. Kanebratt and T. Andersson, Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies, Drug Metabolism and Disposition, vol.36, issue.7, pp.1444-52, 2008.
DOI : 10.1124/dmd.107.020016

R. Kapil, A. Nolting, P. Roy, W. Fiske, I. Benedek et al., Pharmacokinetic properties of combination oxycodone plus racemic ibuprofen: Two randomized, open-label, crossover studies in healthy adult volunteers, Clinical Therapeutics, vol.26, issue.12, pp.2015-2040, 2004.
DOI : 10.1016/j.clinthera.2004.12.013

J. Kindla, F. Müller, M. Mieth, M. F. Fromm, and J. Koenig, Influence of Non-Steroidal Anti-Inflammatory Drugs on Organic Anion Transporting Polypeptide (OATP) 1B1- and OATP1B3-Mediated Drug Transport, Drug Metabolism and Disposition, vol.39, issue.6, pp.1047-1053, 2011.
DOI : 10.1124/dmd.110.037622

I. Kola and J. Landis, Opinion: Can the pharmaceutical industry reduce attrition rates?, Nature Reviews Drug Discovery, vol.1, issue.8, pp.711-716, 2004.
DOI : 10.1038/nrd1470

N. Kramer, M. Krismartina, A. Rico-rico, B. Blaauboer, and J. Hermens, Quantifying Processes Determining the Free Concentration of Phenanthrene in Basal Cytotoxicity Assays, Chemical Research in Toxicology, vol.25, issue.2, pp.436-445, 2012.
DOI : 10.1021/tx200479k

S. Laurent, J. Rahier, A. Geubel, J. Lerut, and Y. Horsmans, Subfulminant hepatitis requiring liver 837 transplantation following ibuprofen overdose, Liver, vol.20, pp.93-97, 2000.

E. Lecluyse and A. E. , Isolation and Culture of Primary Hepatocytes from Resected Human Liver Tissue, Methods Mol Biol, vol.640, pp.57-82, 2010.
DOI : 10.1007/978-1-60761-688-7_3

J. Magdalou, V. Chajes, C. Lafaurie, and G. Siest, Glucuronidation of 2-arylpropionic acids 843 pirprofen, flurbiprofen, and ibuprofen by liver microsomes, Drug Metab Dispos, vol.18, pp.692-697, 1990.

R. Mills, S. Adams, E. Cliffe, W. Dickinson, N. Jsconnor et al., The metabolism of ibuprofen Hepatocellular damage from non-steroidal anti-inflammatory 847 drugs, Xenobiotica QJM, vol.845, issue.96, pp.589-98, 1973.

S. Mueller and L. Richert, Transcriptomic hepatotoxicity signature of chlorpromazine after 850 short-and long-term exposure in primary human sandwich cultures, Drug Metab Dispos, vol.41, pp.1835-851, 2013.

E. Testai, In vitro kinetics of amiodarone and its major metabolite in two human liver cell 854 models after acute and repeated treatments, Toxicol, p.855, 2014.

K. Rainsford, Ibuprofen: pharmacology, efficacy and safety, Inflammopharmacology, vol.80, issue.19, pp.275-856, 2009.
DOI : 10.1007/s10787-009-0016-x

F. Rodríguez-gonzález, J. Montero, J. Puente, E. Fraga, G. Costán et al., Orthotopic liver transplantation after subacute liver failure induced by therapeutic doses of ibuprofen, The American Journal of Gastroenterology, vol.97, issue.9, pp.2476-2483, 2002.
DOI : 10.1016/S0002-9270(02)04372-1

P. Seglen, Chapter 4 Preparation of Isolated Rat Liver Cells, Methods Cell Biol, vol.13, pp.29-83, 1976.
DOI : 10.1016/S0091-679X(08)61797-5

H. Seibert, S. Moerchel, and M. Guelden, Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration, Toxicology in Vitro, vol.16, issue.3, pp.289-97, 2002.
DOI : 10.1016/S0887-2333(02)00014-0

N. Shanks, R. Greek, and J. Greek, Are animal models predictive for humans? Philos Ethics, 2009.

M. Spraul, M. Hofmann, P. Dvortsak, J. Nicholson, and I. Wilson, Liquid chromatography coupled with high-field proton NMR for profiling human urine for endogenous compounds and drug metabolites, Journal of Pharmaceutical and Biomedical Analysis, vol.10, issue.8, pp.601-606, 1992.
DOI : 10.1016/0731-7085(92)80086-3

X. Teng, S. Wang, and N. Davies, Stereospecific high-performance liquid chromatographic analysis of ibuprofen in rat serum, Journal of Chromatography B, vol.796, issue.2, pp.225-256, 2003.
DOI : 10.1016/j.jchromb.2003.07.010

V. Tirelli, T. Catone, L. Turco, D. Consiglio, E. Testai et al., Effects of the pesticide clorpyrifos on an in vitro model of intestinal barrier, Toxicology in Vitro, vol.21, issue.2, pp.308-321
DOI : 10.1016/j.tiv.2006.08.015

G. Tuschl, B. Lauer, and S. Mueller, Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism, Expert Opinion on Drug Metabolism & Toxicology, vol.24, issue.7, pp.855-70, 2008.
DOI : 10.2174/138920005774832632

G. Tuschl, J. Hrach, Y. Walter, P. Hewitt, and S. Mueller, Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: A valuable model for in vitro toxicity and drug???drug interaction studies, Chemico-Biological Interactions, vol.181, issue.1, pp.124-161, 2009.
DOI : 10.1016/j.cbi.2009.05.015

R. Ve?e?a, A. Zacha?ová, J. Orolin, J. Strojil, N. Skottová et al., Fenofibrate-induced decrease of expression of CYP2C11 and CYP2C6 in rat, Biopharmaceutics & Drug Disposition, vol.28, issue.8, pp.482-489, 2011.
DOI : 10.1002/bdd.774

R. Vilenchik, M. Berkovitch, A. Jossifoff, Z. Ben-zvi, and E. Kozer, Oral versus rectal ibuprofen in 880 healthy volunteers, J Popul Ther Clin Pharmacol, vol.19, pp.179-86, 2012.

P. Jennings, Application of integrated transcriptomic, proteomic and metabolomic profiling 885 for the delineation of mechanisms of drug induced cell stress, J Proteomics, vol.79, pp.180-94, 2013.

U. Zanelli, N. Caradonna, D. Hallifax, E. Turlizzi, and J. Houston, Comparison of cryopreserved 887 HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs, Drug Metab Dispos, vol.888, issue.40, pp.104-114, 2012.

A. Zhang, C. Wang, Q. Liu, Q. Meng, J. Peng et al., Involvement of 890 organic anion-transporting polypeptides in thehepatic uptake of dioscin in rats and humans Drug 891, 2013.